Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-370

Just having a celebratory quite glass of bubbles as are a few other Holders from this thread.....

Today DXB announced a Licensing deal

$10m in cash within 30 days and over $200m in Royalties and Milestone Payments over the next year.

Volume up over 40m in a single day and an increase in Share Holder Value of over 100% Today.

The TH was called on the 4th

in that time a concerted effort was made to deliver a presentation of "What the Deal is" " What the Deal Means"

2 minutes after the deal was announced the CEO held a Webinar that SH could sign up to this morning

The CEO "Nina" had a Backdrop with the Company Name Dimerix in clear site behind her,, for the entire webinar so that if stills are taken from the Webinar you can clearly see what company is being represented.

Every major Investment Site had Editorial provided to them under embargo ready to publish and now they have delivered that to the Investment Community

DXB license was for 22% of the Global market (5 Regions) so 78% or the Global Markets still to be licensed with a possible value of $700m

The CEO stated "There is no need for future CR Funding"

What was OBVIOUS was a cohesive and strategic plan was in play for the delivery of the NEWS.. compounding the beneficial value for SH and delivering Market Wide Awareness...

Tonight when Europe and the America's are delivered this news I can see even greater interest and awareness in the Company.

Now if PAA make the same choice to "Push" the MND data then I would hazard a guess the market will react with a similar furor.

Clear Concise well delivered Positive and Valuable NEWS heralded by the Company...will deliver substantial gains here at PAA..

If I use the budget of $100k for PR and Marketing of todays announcement at DXB it returned $30m in SH Value....NZT

You cant whisper "MND Treated by MPL" and expect the same Market Awareness and the same Market Results....